Pursuant to Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of Q4 2023-24 Earnings call held on 27th May 2024, on the website of the Company

pdf

Glenmark Pharmaceuticals Ltd.

27 May 2024

2188.90

0.36%

Glenmark Pharmaceuticals Results Earnings Call for Q4FY24

Conference Call with Glenmark Pharmaceuticals Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.

audio

Glenmark Pharmaceuticals Ltd.

19 Feb 2024

2188.90

0.36%

Earnings Call

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

The transcript of the Earnings Call held on Friday, February 16, 2024 for the third quarter and nine months ended December 31, 2023 has been uploaded on the Company''s website.

pdf

Glenmark Pharmaceuticals Ltd.

16 Feb 2024

2188.90

0.36%

Earnings Call

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of Q3 FY 2023-24 Earnings Call held on 16th February, 2024 on the website of the Company.

pdf

Glenmark Pharmaceuticals Ltd.

16 Feb 2024

2188.90

0.36%

Glenmark Pharmaceuticals Results Earnings Call for Q3FY24

Conference Call with Glenmark Pharmaceuticals Management and Analysts on Q3FY24 Performance and Outlook. Listen to the full earnings transcript.

audio

Glenmark Pharmaceuticals Ltd.

20 Nov 2023

2188.90

0.36%

Earnings Call

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

The transcript of the Earnings Call held on Wednesday, November 15, 2023 for the second quarter and half year ended September 30, 2023 has been uploaded on the Company''s website.

pdf

Glenmark Pharmaceuticals Ltd.

15 Nov 2023

2188.90

0.36%

Earnings Call

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of Q2 FY 2023-24 Earnings Call held on 15th November, 2023 on the website of the Company.

pdf

Glenmark Pharmaceuticals Ltd. Conference Calls and Earnings Call Transcripts

Glenmark Pharmaceuticals Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

Earnings Calls Podcast on